Cargando…
Double Positive CD4(+)CD8(+) T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization
The immune system plays a central role in cancer development, showing both anti-tumor and pro-tumor activities depending on the immune cell subsets and the disease context. While CD8 T cells are associated with a favorable outcome in most cancers, only T helper type 1 (Th1) CD4 T cells play a protec...
Autores principales: | Bohner, Perrine, Chevalier, Mathieu F., Cesson, Valérie, Rodrigues-Dias, Sonia-Christina, Dartiguenave, Florence, Burruni, Rodolfo, Tawadros, Thomas, Valerio, Massimo, Lucca, Ilaria, Nardelli-Haefliger, Denise, Jichlinski, Patrice, Derré, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450069/ https://www.ncbi.nlm.nih.gov/pubmed/30984190 http://dx.doi.org/10.3389/fimmu.2019.00622 |
Ejemplares similares
-
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
por: Nguyen, Sylvain, et al.
Publicado: (2022) -
Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile
por: Lucca, Ilaria, et al.
Publicado: (2022) -
Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
por: Benmerzoug, Sulayman, et al.
Publicado: (2021) -
Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells
por: Decrausaz, Loane, et al.
Publicado: (2013) -
Immunotherapeutic strategies for bladder cancer
por: Chevalier, Mathieu F, et al.
Publicado: (2014)